Vision Loss and NAION: A condition known as non-arteritic anterior ischemic optic neuropathy (NAION) has also emerged as a serious concern among GLP-1 users
The SELECT trial result - 20% reduction in major cardiovascular events with weekly semaglutide 2.4mg in adults with established cardiovascular disease plus overweight/obesity - was the first time a weight-loss medication demonstrated cardiovascular outcome benefits in a major randomized controlled trial
Are Rybelsus and metformin the same thing
This powerful blend combines Omega-3 fatty acids to help regulate cholesterol and triglyceride levels, Coenzyme Q10 to boost cellular energy and heart function, and Lycopene for antioxidant protection against oxidative stress
2 mg (2000 mcg) once daily subcutaneously, the FDA-approved regimen, after an optional 1 mg first-week titration
Which approach is better depends entirely on your situation, goals, and what you plan to do after the medication stops